ArticleScientific reports2024

Camptothecin enhances the anti-tumor effect of low-dose apatinib combined with PD-1 inhibitor on hepatocellular carcinoma.

Hankang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.